Systemic Epstein-Barr virus-positive T-cell lymphoma of childhood

Qiong Wu1, Faliang Ren2, Dirk M Elston3

  • 1Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China.

Cutis
|December 31, 2019
PubMed

Insights

This case study details a rare Epstein-Barr virus (EBV)-positive T-cell lymphoma in a child. The condition initially resolved spontaneously but relapsed, leading to a fatal outcome.

Area of Science:

  • Pediatric Oncology
  • Virology
  • Hematology

Background:

  • Epstein-Barr virus (EBV) is a common herpesvirus that can cause various lymphoproliferative disorders.
  • T-cell lymphomas are a diverse group of cancers affecting T-lymphocytes, often aggressive.
  • Childhood lymphomas require specific diagnostic and therapeutic approaches.

Observation:

  • A 7-year-old boy presented with acute fever, oral ulcers, and skin nodules.
  • Initial presentation lacked pancytopenia and hemophagocytic syndrome.
  • The condition exhibited a period of spontaneous remission.

Findings:

  • Systemic Epstein-Barr virus (EBV)-positive T-cell lymphoma of childhood was diagnosed via comprehensive examination.
  • Diagnostic methods included laboratory tests, imaging, biopsies, immunohistochemistry, and in situ hybridization for EBER.
  • The lymphoma demonstrated an initial spontaneous resolution followed by relapse.

Implications:

  • This case highlights the variable clinical course of EBV-positive T-cell lymphoma in children.
  • The absence of typical indicators like pancytopenia may complicate early diagnosis.
  • Understanding spontaneous remission and relapse patterns is crucial for managing this rare pediatric malignancy.